ICICI Direct is bullish on Zee Entertainment has recommended buy rating on the stock with a target price of Rs 300 in its research report dated August 13, 2022.
Posts tagged MC
Buy Apollo Hospitals: target of Rs 5080: ICICI Direct (16-08-2022)
ICICI Direct is bullish on Apollo Hospitals has recommended buy rating on the stock with a target price of Rs 5080 in its research report dated August 13, 2022.
Buy TV Today Network; target of Rs 350: ICICI Direct (16-08-2022)
ICICI Direct is bullish on TV Today Network has recommended buy rating on the stock with a target price of Rs 350 in its research report dated August 13, 2022.
Buy Zee Entertainment Enterprises; target of Rs 308: Prabhudas Lilladher (16-08-2022)
Prabhudas Lilladher is bullish on Zee Entertainment Enterprises has recommended buy rating on the stock with a target price of Rs 308 in its research report dated August 13, 2022.
Buy Oil and Natural Gas Corporation; target of Rs 160: Prabhudas Lilladher (16-08-2022)
Prabhudas Lilladher is bullish on Oil and Natural Gas Corporation has recommended buy rating on the stock with a target price of Rs 160 in its research report dated August 13, 2022.
Buy Krishna Institute of Medical Sciences; target of Rs 1550: Prabhudas Lilladher (16-08-2022)
Prabhudas Lilladher is bullish on Krishna Institute of Medical Sciences has recommended buy rating on the stock with a target price of Rs 1550 in its research report dated August 13, 2022.
Buy Max Healthcare Institute; target of Rs 427: Prabhudas Lilladher (16-08-2022)
Prabhudas Lilladher is bullish on Max Healthcare Institute has recommended buy rating on the stock with a target price of Rs 427 in its research report dated August 13, 2022.
Accumulate Restaurant Brands Asia; target of Rs 148: Prabhudas Lilladher (16-08-2022)
Prabhudas Lilladher recommended accumulate rating on Restaurant Brands Asia with a target price of Rs 148 in its research report dated August 12, 2022.
Buy Grasim Industries; target of Rs 1881: Sharekhan (16-08-2022)
Sharekhan is bullish on Grasim Industries has recommended buy rating on the stock with a target price of Rs 1881 in its research report dated August 12, 2022.
Buy Divis Laboratories; target of Rs 4450: Sharekhan (16-08-2022)
Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 4450 in its research report dated August 12, 2022.